Is Sermorelin Legal in Georgia? How to Access It Legally
HealthRX.com
No approved sermorelin product, so access runs through compounding
See the public record for Sermorelin
At a glance
- Federal status / No FDA-approved sermorelin product [1]
- Geref / Discontinued 2008; approvals withdrawn June 18, 2009 [1]
- Withdrawal reason / Not safety or effectiveness, March 2013 [1][4]
- Available as / A compounded drug, not FDA-approved [2]
- FDA safety-risk list / Not listed (page dated 04/22/2026) [5]
- Outsourcing-facility nominations / Category 1, under evaluation (updated March 21, 2025) [6]
- Sport / Prohibited at all times by WADA (S2.2.4) [7]
Why there is no approved sermorelin product
Sermorelin acetate was approved twice as Geref: NDA 019863, 0.05 mg per ampule, approved December 28, 1990, for evaluating the pituitary's ability to secrete growth hormone; and NDA 020443, 0.5 mg and 1 mg vials, approved September 26, 1997, for idiopathic growth hormone deficiency in children with growth failure [1]. EMD Serono discontinued both in 2008, asked FDA to withdraw the applications, and FDA withdrew both approvals effective June 18, 2009 [1]. In March 2013 FDA determined Geref had not been withdrawn for reasons of safety or effectiveness [1][4]. Neither application covered adults, anti-aging, weight loss or athletic performance [1].
What sermorelin is
Sermorelin is a 29-amino-acid analogue of human growth hormone-releasing hormone, the shortest synthetic peptide with the full biological activity of GHRH [8]. It prompts the pituitary to release the body's own growth hormone; it is not growth hormone itself [8].
Where sermorelin sits in federal compounding rules
With no approved product, sermorelin is supplied as a compounded drug, and compounded drugs are not FDA-approved: FDA does not review their safety, effectiveness or quality before they are marketed [2]. Under federal law, compounding by a state-licensed pharmacy is exempt from pre-market approval on the condition, among others, that it is based on a valid patient-specific prescription. Outsourcing facilities, a voluntary category of larger registered compounders, may distribute either on a patient-specific prescription or on an order from a health care provider, such as a hospital, that is not for an identified individual patient (for example, office stock) [3]. How Georgia applies its own rules on top of this is not established here.
On FDA's lists, sermorelin is absent from the bulk substances that may present significant safety risks (content dated 04/22/2026) [5] and from every category on the list for state-licensed pharmacies and physicians (updated May 14, 2026) [9]. It is category 1, under evaluation, on the outsourcing-facility nomination list (updated March 21, 2025) [6], and is not one of the six peptides in HHS's October 2026 draft enforcement-discretion policy [10]. None of that is an approval.
Questions worth asking
Sermorelin and drug testing
WADA's 2026 Prohibited List names sermorelin in S2.2.4, its growth hormone releasing factors section, and prohibits it at all times, in and out of competition [7]. The 2027 List names it too [11].
Check what you know
Question 1 of 3
Score: 0 right, 0 of 3 answered
Frequently asked questions
Is sermorelin legal in Georgia?
Is sermorelin FDA-approved today?
Can I get sermorelin without a prescription?
Is sermorelin banned in sport?
References
Show all 11 referencesHide references
- Federal Register :: Request Access.
- Official web page.
- Human Drug Compounding Laws | FDA.
- U.S. Food and Drug Administration.
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA.
- U.S. Food and Drug Administration.
- World Anti-Doping Agency.
- Prakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 1999;12(2):139-57.
- U.S. Food and Drug Administration.
- Official web page.
- World Anti-Doping Agency.